Clinical Trial Update: Intensity-Modulated Radiotherapy for Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intensity-modulated radiotherapy for recurrent head and neck cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Nilam Ramsinghani | Conditions: Carcinoma of the Head and Neck | Phase 2 | Status: WITHDRAWN